Cytek Biosciences, Inc.
CTKB· Nasdaq
Released May 11, 2022, after the close
10-Q filed May 12, 2022, 42 days after period end · 0000950170-22-009425
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Revenue | $35.06M | $24.27M | — |
| Net Income | -$2.16M | $102.00K | -$839.00K |
| EPS Diluted | $0.02 | $0.00 | — |
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.